Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
Cognitive testing for early detection of Alzheimer's disease in people with Down syndrome: a systematic review and meta-analysis.
FY 2020-21
Summary
Alzheimer's disease (AD) is an increasing problem for people with Down syndrome (DS) . AD is a neurodegenerative disease which is characterized by brain lesions, multiple cognitive symptoms such as memory loss accompanied by a gradual autonomy loss. The development of brain lesions can appear years before AD. Through this progressive neuronal loss, patients can firstly begin to have a a perception of cognitive difficulties, i.e., a subjective cognitive decline (SCD). This preclinical phase ends with the onset of mild cognitive impairment (MCI) which is characterized by a set of cognitive symptoms, including memory loss while not affecting the daily living activities functioning. Knowing that people with DS have already pre-existing cognitive deficits, screening at the preclinical and clinical stages of AD therefore cannot be done through traditional cognitive tests. To date, several cognitive tests have been developed to screen for cognitive changes related to the development of AD in people with DS. A recent study has shown that difficulties in executive functions and memory are early signs of AD and especially of the MCI stage in individuals with DS. Knowing that cognitive tests adapted to people with DS finely assess memory and executive functions, we believe that these tests would make it possible to diagnose as many people with DS as possible in one of the early stages of AD by detecting only those actually in one of these stages. The present research will first, through a systematic review, identify studies that have used cognitive tests for the diagnosis of AD, MCI or SCD in people with DS. Then, through a meta-analysis, the real magnitude of each of the tests will be quantified thus putting them on the same basis of analysis in order to compare them.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449308
Name
Nadeau Patricia A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cognitive testing for early detection of Alzheimer's disease in people with Down syndrome: a systematic review and meta-analysis.
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Cognition; Cognitive Assessment; Down Syndrome; Executive Fonction; Intellectual Disability; Memory; Mild Cognitive Impairment; Subjective Cognitive Decline; Trisomy 21
Abstract
Alzheimer's disease (AD) is an increasing problem for people with Down syndrome (DS) . AD is a neurodegenerative disease which is characterized by brain lesions, multiple cognitive symptoms such as memory loss accompanied by a gradual autonomy loss. The development of brain lesions can appear years before AD. Through this progressive neuronal loss, patients can firstly begin to have a a perception of cognitive difficulties, i.e., a subjective cognitive decline (SCD). This preclinical phase ends with the onset of mild cognitive impairment (MCI) which is characterized by a set of cognitive symptoms, including memory loss while not affecting the daily living activities functioning. Knowing that people with DS have already pre-existing cognitive deficits, screening at the preclinical and clinical stages of AD therefore cannot be done through traditional cognitive tests. To date, several cognitive tests have been developed to screen for cognitive changes related to the development of AD in people with DS. A recent study has shown that difficulties in executive functions and memory are early signs of AD and especially of the MCI stage in individuals with DS. Knowing that cognitive tests adapted to people with DS finely assess memory and executive functions, we believe that these tests would make it possible to diagnose as many people with DS as possible in one of the early stages of AD by detecting only those actually in one of these stages. The present research will first, through a systematic review, identify studies that have used cognitive tests for the diagnosis of AD, MCI or SCD in people with DS. Then, through a meta-analysis, the real magnitude of each of the tests will be quantified thus putting them on the same basis of analysis in order to compare them.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nadeau, Patricia A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~